These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8072437)
1. Estrogens and Parkinson's disease. Session DR; Pearlstone MM; Jewelewicz R; Kelly AC Med Hypotheses; 1994 Apr; 42(4):280-2. PubMed ID: 8072437 [TBL] [Abstract][Full Text] [Related]
2. Is there a connection between estrogen and Parkinson's disease? Shulman LM Parkinsonism Relat Disord; 2002 Jun; 8(5):289-95. PubMed ID: 15177058 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and Parkinson's disease. Kompoliti K Front Biosci; 2003 May; 8():s391-400. PubMed ID: 12700049 [TBL] [Abstract][Full Text] [Related]
8. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Liu B; Dluzen DE Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209 [TBL] [Abstract][Full Text] [Related]
9. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917 [TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of estrogen target tissues: implications for estrogen regulation of serum luteinizing hormone. Kelner KL; Peck EJ J Neurosci Res; 1984; 11(1):79-89. PubMed ID: 6708135 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease. Dluzen DE; McDermott JL J Gend Specif Med; 2000; 3(6):36-42. PubMed ID: 11253381 [TBL] [Abstract][Full Text] [Related]
12. Menstrual-related changes in motoric function in women with Parkinson's disease. Kompoliti K; Comella CL; Jaglin JA; Leurgans S; Raman R; Goetz CG Neurology; 2000 Nov; 55(10):1572-5. PubMed ID: 11094119 [TBL] [Abstract][Full Text] [Related]
20. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Morissette M; Al Sweidi S; Callier S; Di Paolo T Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]